Natticha Sumneang

6PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersRespiratory diseasesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 07, 2024
Blocking Brain Myeloid Differentiation Factor 2-Toll-like Receptor 4 Signaling Improves Cognition by Diminishing Brain Pathologies and Preserving Adult Hippocampal Neurogenesis in Obese Rats.

Thura Tun Oo, Natticha Sumneang, Titikorn Chunchai

|Sep 14, 2024
Aerobic Exercise Attenuates Doxorubicin-Induced Cardiomyopathy by Suppressing NLRP3 Inflammasome Activation in a Rat Model.

Phichaya Suthivanich, Worakan Boonhoh, Natticha Sumneang

|Jun 10, 2023
Toll-like Receptor 4 Inflammatory Perspective on Doxorubicin-Induced Cardiotoxicity.

Natticha Sumneang, Pongpan Tanajak, Thura Tun Oo

Pageof 1